Abstract
ABSTRACT
The kinetics of topical triamterene penetration were estimated from the time-course measurements of triamterene (in Dyazide®) concentrations in the anterior chamber of six rabbits (n=12, left and right eyes). The two-compartment model of Jones and Maurice (1) was fitted to the measurements. We found the apparent elimination rate constant of triamterene A = 0.33 ± 0.12 hr−1, the apparent absorption rate constant of triamterene B = 2.68 ± 0.55 hr−1, the cornea-aqueous transfer coefficient in reference to the corneal volume of triamterene kc.ca = 0.28 ± 0.05 hr−1, the loss coefficient of triamterene from the anterior chamber k0 = 0.43 ± 0.16 hr−1 and the amount of triamterene in the comea at time zero M0 = 483 ± 125 ng/ml. The mean of k0 = 0.43 hr−1 is significantly lower (p = 0.04% using ZTEST) than the lower limit of aqueous loss coefficient = 0.58 hr−1 usually found in rabbits (2). We conclude that Dyazide® lowers the aqueous flow rate in the positive direction, considering glaucoma treatment. Peak triamterene concentration in the anterior chamber was P = 120 ± 32 ng/ml. Half-life for elimination from the aqueous humor was T1/2 = 1.84 ± 0.65 hr (Mean ± SD).
Get full access to this article
View all access options for this article.
